Conor McClenaghan

1.3k total citations
32 papers, 841 citations indexed

About

Conor McClenaghan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Conor McClenaghan has authored 32 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Pathology and Forensic Medicine and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Conor McClenaghan's work include Cardiac Ischemia and Reperfusion (17 papers), Ion channel regulation and function (14 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Conor McClenaghan is often cited by papers focused on Cardiac Ischemia and Reperfusion (17 papers), Ion channel regulation and function (14 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Conor McClenaghan collaborates with scholars based in United States, United Kingdom and Italy. Conor McClenaghan's co-authors include Colin G. Nichols, Stephen J. Tucker, Prafulla Aryal, Elisabeth P. Carpenter, Mark S.P. Sansom, Michael V. Clausen, Yin Yao Dong, A.C.W. Pike, Thomas Baukrowitz and Marcus Schewe and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Conor McClenaghan

32 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conor McClenaghan United States 16 525 182 163 157 119 32 841
Guillaume Calmettes United States 16 646 1.2× 92 0.5× 163 1.0× 39 0.2× 199 1.7× 35 1.1k
Jeremy Thompson United States 17 462 0.9× 140 0.8× 122 0.7× 71 0.5× 113 0.9× 41 936
Miroslav Důra United States 12 852 1.6× 53 0.3× 568 3.5× 189 1.2× 159 1.3× 22 1.5k
Jean‐Yves Lapointe Canada 24 1.1k 2.0× 78 0.4× 157 1.0× 225 1.4× 279 2.3× 58 1.7k
Tamio Ieiri Japan 24 625 1.2× 61 0.3× 65 0.4× 202 1.3× 214 1.8× 55 1.7k
Rafael Mejía-Alvarez United States 15 597 1.1× 155 0.9× 433 2.7× 279 1.8× 43 0.4× 23 823
Guoyong Li China 16 1.1k 2.1× 135 0.7× 211 1.3× 90 0.6× 81 0.7× 41 1.6k
Alexander Kushnir United States 14 845 1.6× 68 0.4× 844 5.2× 222 1.4× 86 0.7× 44 1.3k
Sabine Bartel Germany 23 963 1.8× 124 0.7× 861 5.3× 155 1.0× 164 1.4× 61 1.5k
Piotr Koprowski Poland 18 774 1.5× 130 0.7× 77 0.5× 146 0.9× 232 1.9× 36 1.0k

Countries citing papers authored by Conor McClenaghan

Since Specialization
Citations

This map shows the geographic impact of Conor McClenaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conor McClenaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conor McClenaghan more than expected).

Fields of papers citing papers by Conor McClenaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conor McClenaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conor McClenaghan. The network helps show where Conor McClenaghan may publish in the future.

Co-authorship network of co-authors of Conor McClenaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Conor McClenaghan. A scholar is included among the top collaborators of Conor McClenaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conor McClenaghan. Conor McClenaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metwally, Elsayed, Evan Yamasaki, Pratish Thakore, et al.. (2024). Mitochondrial Ca2+-coupled generation of reactive oxygen species, peroxynitrite formation, and endothelial dysfunction in Cantú syndrome. JCI Insight. 9(17). 5 indexed citations
2.
Sala‐Rabanal, Monica, Zeynep Yurtsever, Conor McClenaghan, et al.. (2024). Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cells. Journal of Biological Chemistry. 300(7). 107432–107432. 2 indexed citations
3.
Maqoud, Fatima, Conor McClenaghan, Theresa M. Harter, et al.. (2023). Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome. Cells. 12(6). 928–928. 3 indexed citations
4.
McClenaghan, Conor, et al.. (2023). Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS. EMBO Molecular Medicine. 15(6). e16883–e16883. 3 indexed citations
5.
Gao, Jian, Conor McClenaghan, Kenneth A. Matreyek, Dorothy K. Grange, & Colin G. Nichols. (2023). Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome KATP Channel Mutations in Intact Cells. Journal of Pharmacology and Experimental Therapeutics. 386(3). 298–309. 7 indexed citations
6.
Singh, Gautam K., Conor McClenaghan, Hongjie Gu, et al.. (2022). A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome. Journal of the American Heart Association. 11(24). e027363–e027363. 8 indexed citations
7.
McClenaghan, Conor, Novella Rapini, Domenico Umberto De Rose, et al.. (2022). Sulfonylurea-Insensitive Permanent Neonatal Diabetes Caused by a Severe Gain-of-Function Tyr330His Substitution in Kir6.2. Hormone Research in Paediatrics. 95(3). 215–223. 2 indexed citations
8.
Maqoud, Fatima, Nicola Zizzo, Giuseppe Passantino, et al.. (2021). Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome. Cells. 10(7). 1791–1791. 14 indexed citations
9.
Zhang, Haixia, Christopher H. Emfinger, Conor McClenaghan, et al.. (2021). Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice. JCI Insight. 6(5). 10 indexed citations
10.
11.
McClenaghan, Conor, Yan Huang, Scot J. Matkovich, et al.. (2020). The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú Syndrome. Function. 1(1). zqaa004–zqaa004. 16 indexed citations
12.
McClenaghan, Conor, et al.. (2020). Coronavirus Proteins as Ion Channels: Current and Potential Research. Frontiers in Immunology. 11. 573339–573339. 55 indexed citations
13.
McClenaghan, Conor, Yan Huang, Zihan Yan, et al.. (2019). Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivity. Journal of Clinical Investigation. 130(3). 1116–1121. 30 indexed citations
14.
Aryal, Prafulla, Michael V. Clausen, Marcus Schewe, et al.. (2017). Bilayer-Mediated Structural Transitions Control Mechanosensitivity of the TREK-2 K2P Channel. Structure. 25(5). 708–718.e2. 58 indexed citations
15.
McClenaghan, Conor, Monica Sala‐Rabanal, Helen I. Roessler, et al.. (2017). Cantu syndrome–associated SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms. Journal of Biological Chemistry. 293(6). 2041–2052. 27 indexed citations
16.
Cooper, Paige, Conor McClenaghan, Xingyu Chen, Anna Stary‐Weinzinger, & Colin G. Nichols. (2017). Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel. Journal of Biological Chemistry. 292(42). 17387–17398. 24 indexed citations
17.
Dong, Yin Yao, A.C.W. Pike, Alexandra Mackenzie, et al.. (2015). K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Science. 347(6227). 1256–1259. 237 indexed citations
18.
McClenaghan, Conor, et al.. (2015). Mechanisms of TREK-2 Potassium Channel Gating. Biophysical Journal. 108(2). 437a–437a. 1 indexed citations
19.
McClenaghan, Conor, Fanning Zeng, & J. Martin Verkuyl. (2012). TRPA1 Agonist Activity of Probenecid Desensitizes Channel Responses: Consequences for Screening. Assay and Drug Development Technologies. 10(6). 533–541. 13 indexed citations
20.
Watson, Robert P., Elliot Lilley, Moh Panesar, et al.. (2011). Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport. Neurogastroenterology & Motility. 24(1). 65–65. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillaume Calmettes Breakdown of academic impact, for papers by Jeremy Thompson Breakdown of academic impact, for papers by Miroslav Důra Breakdown of academic impact, for papers by Jean‐Yves Lapointe Breakdown of academic impact, for papers by Tamio Ieiri Breakdown of academic impact, for papers by Rafael Mejía-Alvarez Breakdown of academic impact, for papers by Guoyong Li Breakdown of academic impact, for papers by Alexander Kushnir Breakdown of academic impact, for papers by Sabine Bartel Breakdown of academic impact, for papers by Piotr Koprowski
Rankless by CCL
2026